July 17, 2024 11:21 AM EDTUpdated 01:06 PM

Big three PBMs will testify before Congress next week, following FTC report

Drew Armstrong

Executive Editor

Pharmacy benefit manager executives from Cigna, CVS Health and UnitedHealth Group are scheduled to testify before Congress on July 23, giving lawmakers a chance to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Big three PBMs will testify before Congress next week, following FTC report

Drew Armstrong

Executive Editor

Sign up to read this article for free.

Ipsen sells priority review voucher for highest price since 2016

Updated: Alnylam’s new Phase 3 ATTR data bring uncertainty to standard of care ambitions

J&J's human resources leader to retire; Amgen becomes the newest pharma with a top AI exec

Merck opens London lab as it makes push into immunology and the UK

FDA approves Emergent vaccine for mpox as company plans to donate 50,000 doses

Biosecure vote slated for September

Big three PBMs will tes­ti­fy be­fore Con­gress next week, fol­low­ing FTC re­port

Drew Armstrong

Executive Editor

Sign up to read this article for free.

more like this

Ipsen sells pri­or­i­ty re­view vouch­er for high­est price since 2016

Up­dat­ed: Al­ny­lam’s new Phase 3 AT­TR da­ta bring un­cer­tain­ty to stan­dard of care am­bi­tions

J&J's hu­man re­sources leader to re­tire; Am­gen be­comes the newest phar­ma with a top AI ex­ec

Mer­ck opens Lon­don lab as it makes push in­to im­munol­o­gy and the UK

FDA ap­proves Emer­gent vac­cine for mpox as com­pa­ny plans to do­nate 50,000 dos­es

Biose­cure vote slat­ed for Sep­tem­ber

Big three PBMs will testify before Congress next week, following FTC report

Ipsen sells priority review voucher for highest price since 2016

Updated: Alnylam’s new Phase 3 ATTR data bring uncertainty to standard of care ambitions

J&J's human resources leader to retire; Amgen becomes the newest pharma with a top AI exec

Merck opens London lab as it makes push into immunology and the UK

FDA approves Emergent vaccine for mpox as company plans to donate 50,000 doses

Biosecure vote slated for September